FDA grants Orphan Drug Designation for narcolepsy treatment
The FDA has given the XWL-008 compound Orphan Drug Designation for the treatment of narcolepsy.
List view / Grid view
News
GSK reported to have started the sale of $1.2 billion consumer health drugs
According to Reuters, GSK has started the sale of some consumer health brands as it seeks to raise £1 billion.
New partnership established to develop an innovation lab
Google and Sanofi have partnered to develop an innovation lab for the advancement of health services.
Global diabetes drug market expected to rise 3.6 percent
A new report predicts that the global diabetes drug market will rise to US$58.4 billion by 2025.
China announces generic drug list to reduce pharmaceutical costs
Chinese government introduces initiative to enable generic drugs to enter market and reduce prices.
FDA approves treatment for sexual dysfunction in premenopausal women
The FDA has announced its approval of a therapy for hypoactive sexual desire disorder in premenopausal women.
FDA plans to institutionalise drug compounding
The FDA has told its staff that it will be assigning drug compounding to the Office of Compliance.
Job cuts limit cardiovascular and diabetes research and development
Pharmaceutical company, Sanofi, will eliminate jobs in France and Germany and end new in-house cardiology research programmes.
Manufacturing of paediatric medicines set to improve with new investments
A pharmaceutical company and a local council have announced investments to improve paediatric medicines manufacturing.
US$150 million invested to expand US pharmaceutical distribution network
DHL Supply Chain is investing millions of dollars to expand its pharmaceutical and medical device distribution network in the US.
Premier Pharmacy Labs recalls products after FDA inspection
The company has announced a recall of products which were intended to be sterile after a lack of sterility assurance.
FDA announces new data points to aid generic drug developers
The FDA has released new data points which increase transparency for generic-drug competitors.
Lynparza has been approved for BRCA-mutated advanced ovarian cancer
BRCA-mutated advanced ovarian cancer treatment has been approved by the European Commission.
FDA joins blockchain system for drug safety
A multi-company system to improve traceability of pharmaceutical products is newly supported by the FDA.
Four pharmaceutical companies accused of illegal anti-competitive conduct
The CMA has revealed findings that provisionally show that four pharmaceutical companies have broken the law.
